The Department of Health and Human Services maintains a list of state-specific ... Often referred to as PrEP, or “pre-exposure prophylaxis,” these drugs are approved for men at high risk ...
GSK’s majority-owned HIV unit ViiV has agreed licensing deals with a trio of generic manufacturers to make its recently-approved long-acting drug for pre-exposure prophylaxis (PrEP) available in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback